Pharmaceuticals, Biotechnology and Life Sciences
– Tivozanib assigned PDUFA target action date of March 31, 2021; FDA indicates that it does not currently plan to…
VANCOUVER, British Columbia–(BUSINESS WIRE)–#AbCellera–AbCellera today announced that LY-CoV555, the lead antibody from the collaboration between AbCellera and Eli Lilly and…
Regeneron Pharmaceuticals and Sanofi have shared positive results from Part A of the pivotal Phase 3 trial evaluating Dupixent in patients 12 years and older with eosinophilic esophagitis (EoE), in which the trial met both co-primary endpoints.
LONDON–(BUSINESS WIRE)–#BiopharmaceuticalAnalyticalTestingServicesMarket–Technavio has been monitoring the biopharmaceutical analytical testing services market and it is poised to grow by USD 1.18…
Bioparticle-based delivery system offers potential as a coronavirus therapy LOS ANGELES–(BUSINESS WIRE)–An emerging company developing biotechnology invented at UCLA is…
Mylan is potentially getting access to 14 indications after approval, as first neurotoxin formulation to be developed as a potential biosimilar product to BOTOX.
OSAKA, Japan & FLORHAM PARK, N.J.–(BUSINESS WIRE)–Shionogi & Co., Ltd. (hereafter “Shionogi”) today announced the U.S. Food and Drug Administration…
BETHESDA, Md. & AUSTIN, Texas–(BUSINESS WIRE)–Longhorn Vaccines & Diagnostics, an innovative molecular tool, assay and vaccine development company focused on…
NEW YORK–(BUSINESS WIRE)–Treadwell Therapeutics, a clinical-stage biotechnology company developing novel therapeutics for highly aggressive cancers, today announced that members of…
SAN FRANCISCO–(BUSINESS WIRE)–The Larvol Group, a Software as a Service (SaaS) company with 125 employees, announced the launch of Veri,…